Mathieu D Vargot
Examiner (ID: 5376, Phone: (571)272-1211 , Office: P/1742 )
Most Active Art Unit | 1732 |
Art Unit(s) | 1742, 1791, 1732, 1305, 2899, 1307 |
Total Applications | 3254 |
Issued Applications | 2227 |
Pending Applications | 219 |
Abandoned Applications | 808 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8652660
[patent_doc_number] => 08372405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Proteins with improved solubility and methods for producing and using same'
[patent_app_type] => utility
[patent_app_number] => 13/252671
[patent_app_country] => US
[patent_app_date] => 2011-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 9807
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13252671
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/252671 | Proteins with improved solubility and methods for producing and using same | Oct 3, 2011 | Issued |
Array
(
[id] => 7719835
[patent_doc_number] => 20120009170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'METHOD OF TREATING INFLAMMATORY LUNG DISEASE WITH SUPPRESSORS OF CpG OLIGONUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/237831
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11646
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009170.pdf
[firstpage_image] =>[orig_patent_app_number] => 13237831
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/237831 | Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides | Sep 19, 2011 | Issued |
Array
(
[id] => 8738047
[patent_doc_number] => 08409817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'Methods and compositions for detection of Ehrlichia chaffeensis (VLPT)'
[patent_app_type] => utility
[patent_app_number] => 13/162671
[patent_app_country] => US
[patent_app_date] => 2011-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 14308
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13162671
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/162671 | Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) | Jun 16, 2011 | Issued |
Array
(
[id] => 5936211
[patent_doc_number] => 20110212230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'Evaluating bacterial lethality of containerized food production'
[patent_app_type] => utility
[patent_app_number] => 13/067022
[patent_app_country] => US
[patent_app_date] => 2011-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8907
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212230.pdf
[firstpage_image] =>[orig_patent_app_number] => 13067022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/067022 | Evaluating bacterial lethality of containerized food production | May 2, 2011 | Abandoned |
Array
(
[id] => 8339687
[patent_doc_number] => 08241610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/083385
[patent_app_country] => US
[patent_app_date] => 2011-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 12193
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13083385
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/083385 | Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines | Apr 7, 2011 | Issued |
Array
(
[id] => 6164971
[patent_doc_number] => 20110195092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'LIVE ATTENUATED ALDOLASE-NEGATIVE BACTERIAL VACCINE'
[patent_app_type] => utility
[patent_app_number] => 13/035137
[patent_app_country] => US
[patent_app_date] => 2011-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4019
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195092.pdf
[firstpage_image] =>[orig_patent_app_number] => 13035137
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/035137 | Live attenuated aldolase-negative bacterial vaccine | Feb 24, 2011 | Issued |
Array
(
[id] => 8591700
[patent_doc_number] => 08349575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Relay vaccine'
[patent_app_type] => utility
[patent_app_number] => 13/029884
[patent_app_country] => US
[patent_app_date] => 2011-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11133
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13029884
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/029884 | Relay vaccine | Feb 16, 2011 | Issued |
Array
(
[id] => 6212369
[patent_doc_number] => 20110135669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'SYNTHETIC AGONISTS OF TLR9'
[patent_app_type] => utility
[patent_app_number] => 12/960030
[patent_app_country] => US
[patent_app_date] => 2010-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17257
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20110135669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12960030
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/960030 | SYNTHETIC AGONISTS OF TLR9 | Dec 2, 2010 | Abandoned |
Array
(
[id] => 9323367
[patent_doc_number] => 08658386
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-02-25
[patent_title] => 'Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis'
[patent_app_type] => utility
[patent_app_number] => 12/951434
[patent_app_country] => US
[patent_app_date] => 2010-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10448
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12951434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/951434 | Hybridomas producing highly specific monoclonal antibodies to detect mycobacterium avium subspecies paratuberculosis | Nov 21, 2010 | Issued |
Array
(
[id] => 6007036
[patent_doc_number] => 20110059067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES'
[patent_app_type] => utility
[patent_app_number] => 12/941705
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4012
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059067.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941705
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941705 | MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES | Nov 7, 2010 | Abandoned |
Array
(
[id] => 5975999
[patent_doc_number] => 20110070266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS'
[patent_app_type] => utility
[patent_app_number] => 12/896353
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 48227
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896353
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896353 | IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS | Sep 30, 2010 | Abandoned |
Array
(
[id] => 8870891
[patent_doc_number] => 08466268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Lactobacillus sp. JNU2116 with antimutagenic activity'
[patent_app_type] => utility
[patent_app_number] => 12/862855
[patent_app_country] => US
[patent_app_date] => 2010-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4836
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12862855
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/862855 | Lactobacillus sp. JNU2116 with antimutagenic activity | Aug 24, 2010 | Issued |
Array
(
[id] => 6184010
[patent_doc_number] => 20110123561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE'
[patent_app_type] => utility
[patent_app_number] => 12/855671
[patent_app_country] => US
[patent_app_date] => 2010-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26799
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123561.pdf
[firstpage_image] =>[orig_patent_app_number] => 12855671
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/855671 | METHODS AND COMPOSITIONS FOR INDUCTION OR PROMOTION OF IMMUNE TOLERANCE | Aug 11, 2010 | Abandoned |
Array
(
[id] => 8858355
[patent_doc_number] => 08460890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Detection and measurement of blood-feeding activity'
[patent_app_type] => utility
[patent_app_number] => 12/789757
[patent_app_country] => US
[patent_app_date] => 2010-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 7543
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12789757
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/789757 | Detection and measurement of blood-feeding activity | May 27, 2010 | Issued |
Array
(
[id] => 6493843
[patent_doc_number] => 20100209448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-19
[patent_title] => 'SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/750329
[patent_app_country] => US
[patent_app_date] => 2010-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6078
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20100209448.pdf
[firstpage_image] =>[orig_patent_app_number] => 12750329
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/750329 | SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES | Mar 29, 2010 | Abandoned |
Array
(
[id] => 4493803
[patent_doc_number] => 07947290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'Protease-resistant modified SEB and vaccine containing the same'
[patent_app_type] => utility
[patent_app_number] => 12/644952
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 5509
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947290.pdf
[firstpage_image] =>[orig_patent_app_number] => 12644952
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/644952 | Protease-resistant modified SEB and vaccine containing the same | Dec 21, 2009 | Issued |
Array
(
[id] => 6372841
[patent_doc_number] => 20100080823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants'
[patent_app_type] => utility
[patent_app_number] => 12/590548
[patent_app_country] => US
[patent_app_date] => 2009-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10205
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20100080823.pdf
[firstpage_image] =>[orig_patent_app_number] => 12590548
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/590548 | Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants | Nov 9, 2009 | Issued |
Array
(
[id] => 8339921
[patent_doc_number] => 08241844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-14
[patent_title] => 'Methods and compositions for modulating an immune response with immunogenic oligonucleotides'
[patent_app_type] => utility
[patent_app_number] => 12/572494
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11249
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12572494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/572494 | Methods and compositions for modulating an immune response with immunogenic oligonucleotides | Oct 1, 2009 | Issued |
Array
(
[id] => 5397776
[patent_doc_number] => 20090317839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'BOTULINUM TOXIN SCREENING ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 12/545647
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 34891
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20090317839.pdf
[firstpage_image] =>[orig_patent_app_number] => 12545647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/545647 | Botulinum toxin screening assays | Aug 20, 2009 | Issued |
Array
(
[id] => 6638377
[patent_doc_number] => 20100035975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'METHODS OF PREVENTING AND TREATING RESPIRATORY VIRAL INFECTION USING IMMUNOMODULATORY POLYNUCLEOTIDE SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 12/510849
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13932
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035975.pdf
[firstpage_image] =>[orig_patent_app_number] => 12510849
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/510849 | Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide sequences | Jul 27, 2009 | Issued |